A detailed history of Velan Capital Investment Management LP transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 50,000 shares of BOLT stock, worth $25,000. This represents 0.06% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$25,000
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.5 - $0.68 $25,000 - $34,000
50,000 New
50,000 $27,000
Q1 2023

May 15, 2023

BUY
$1.29 - $1.66 $180,600 - $232,400
140,000 New
140,000 $194,000

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $18.8M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.